ALNYLAM PHARMACEUTICALS INC (ALNY) Institutional Ownership and Insiders Activity
ALNYLAM PHARMACEUTICALS INC (ALNY) is widely held by institutional investors, with 742 firms reporting positions valued at approximately $32.60B based on SEC Form 13F filings for the quarter ended September 30, 2026.
Capital World Investors is the largest disclosed holder, reporting approximately $3.41B in ALNY holdings in its latest filing.
Recent insider activity includes 5 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
742
Total Reported Value
$32.60B
Largest Holder
Capital World Investors
Largest Position
$3.41B
Insider Transactions (90d)
5
Latest Filing Quarter
Q3 2026
New Institutional Positions
813
Funds Exiting Positions
2
Top Institutional Owners
View allInvestorReported Balance
- Capital World Investors$3.41B
- Fmr Llc$3.11B
- Blackrock, Inc.$2.72B
- Capital Research Global Investors$2.70B
- T. Rowe Price Investment Management, Inc.$1.70B
Related ALNY Institutional Insights:
- ALNY 13F Institutional Holders
- ALNY Superinvestors
- ALNY Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ALNY Insider Trading & SEC Form 4 Activity
- ALNY Articles
- Top Institutional Investor Stock Rankings